BIIB | Financial Buzz

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Biogen and Sage Therapeutics Collaborate to Develop and Commercialize Potential Therapies in Depression and Movement Disorders

Danny Abramov11/27/2020

18272

Biogen Inc. (NASDAQ: BIIB) and Sage Therapeutics, Inc. (NASDAQ: SAGE) have collaborated to develop and commercialize zuranolone and SAGE-324. Zuranolone is used to treat postpartum depression, major depressive disorder...

Investing News Life Style Market News Medical Use Products The Market Buzz Your Environment

Biogen Surges Following Positive Feedback from FDA Staff

Rebecca Urena11/04/2020

2646

Biogen (NASDAQ: BIIB) surged 42% during morning trading Wednesday amid Food and Drug Administration staff statements that they have gathered enough information to possibly approve its experimental Alzheimer’s drug...

Biotechnology Investing News Market News The Market Buzz

Biogen Announces Second Quarter Financial Results

Nikita Medvedev07/22/2020

4972

Biogen Inc. (NASDAQ: BIIB) announced second quarter financial results. The company reported revenues of 3.682 Billion or 2% increase compared to the same period a year ago. Multiple sclerosis...

Tag: BIIB

Biogen and Sage Therapeutics Collaborate to Develop and Commercialize Potential Therapies in Depression and Movement Disorders

Biogen Surges Following Positive Feedback from FDA Staff

Biogen Announces Second Quarter Financial Results

ABOUT US

Tweets